TCL-391 Valemetostat Monotherapy in Patients with Relapsed/Refractory Non-Hodgkin Lymphomas: Primary Results from a Phase 1 Trial
Clinical Lymphoma Myeloma and Leukemia(2024)
Key words
TCL,clinical trial,EZH2,non-Hodgkin lymphoma,phase 1
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined